A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
Recruiting
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
12/05/2023
Locations: Medical University of South Carolina, Charleston, South Carolina +1 locations
Conditions: Crohn's Disease
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting
The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/18/2023
Locations: Gastroenterology Associates of Orangeburg, Orangeburg, South Carolina
Conditions: Crohn's Disease
A Study of CDPATH™ to Help Manage and Treat Crohn's Disease
Recruiting
CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. The main aim of the study is to explore the use of CDPATH™ to describe a participant's risk profile and to have discussions with their doctor about the potential path of their Crohn's disease. The number of visits will be decided by the study clinic according to their standard practice.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/23/2023
Locations: Palmetto Primary Care Physician Division of Gastroenterology, Summerville, South Carolina
Conditions: Crohn's Disease